Cargando…

Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?

SIMPLE SUMMARY: There is no broad consensus concerning the management of recurrent glioblastoma (rGB). Within the French GB biobank (FGB), systemic treatment is the principal second-line treatment. None of the systemic treatment regimens was unequivocally better than the others for rGB patients. An...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clavreul, Anne, Autier, Lila, Lemée, Jean-Michel, Augereau, Paule, Soulard, Gwénaëlle, Bauchet, Luc, Figarella-Branger, Dominique, Menei, Philippe, Network, FGB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688811/ https://www.ncbi.nlm.nih.gov/pubmed/36428604 http://dx.doi.org/10.3390/cancers14225510

Ejemplares similares

The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2019)

Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2020)

A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide
por: Clavreul, Anne, et al.
Publicado: (2021)

Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link
por: Lemée, Jean-Michel, et al.
Publicado: (2018)

Virtual Reality-Assisted Awake Craniotomy: A Retrospective Study
por: Bernard, Florian, et al.
Publicado: (2023)

Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study
por: Fabbro-Peray, Pascale, et al.
Publicado: (2018)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019)

Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
por: Clavreul, Anne, et al.
Publicado: (2018)

Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
por: Clavreul, Anne, et al.
Publicado: (2017)

‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2015)

Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
por: Clavreul, Anne, et al.
Publicado: (2015)

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2016)

Immersive Virtual Reality and Ocular Tracking for Brain Mapping During Awake Surgery: Prospective Evaluation Study
por: Casanova, Morgane, et al.
Publicado: (2021)

Deciphering the Action of Neuraminidase in Glioblastoma Models
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2023)

Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells
por: Lamballe, Fabienne, et al.
Publicado: (2016)

Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice
por: Ricard, Clément, et al.
Publicado: (2016)

Frontal aslant tract in the non-dominant hemisphere: A systematic review of anatomy, functions, and surgical applications
por: Gallet, Clémentine, et al.
Publicado: (2022)

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide
por: Etcheverry, Amandine, et al.
Publicado: (2014)

Molecular heterogeneity of glioblastomas: does location matter?
por: Denicolaï, Emilie, et al.
Publicado: (2015)

Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?
por: Clavreul, Anne, et al.
Publicado: (2020)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2014)

Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma
por: Berges, Raphael, et al.
Publicado: (2018)

Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells
por: Baeza-Kallee, Nathalie, et al.
Publicado: (2019)

Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo
por: Denicolaï, Emilie, et al.
Publicado: (2014)

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo
por: Berges, Raphael, et al.
Publicado: (2014)

Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool
por: Tsvetkov, Philipp O., et al.
Publicado: (2018)

Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
por: Amoureux, Marie-Claude, et al.
Publicado: (2010)

EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis
por: Bergès, Raphaël, et al.
Publicado: (2020)

Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma
por: Sourty, Baptiste, et al.
Publicado: (2022)

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
por: Tabouret, Emeline, et al.
Publicado: (2015)

Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis
por: Pagano, Alessandra, et al.
Publicado: (2021)

Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma
por: Alzial, Gabriel, et al.
Publicado: (2021)

Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells
por: Guelfi, Sophie, et al.
Publicado: (2016)

SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme
por: Guelfi, Sophie, et al.
Publicado: (2021)

An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
por: Laffaire, Julien, et al.
Publicado: (2014)

Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population
por: Muracciole, Xavier, et al.
Publicado: (2018)

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152
por: Tchoghandjian, A, et al.
Publicado: (2016)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Immune-checkpoint inhibitors for glioblastoma: what have we learned?
por: Omuro, Antonio
Publicado: (2022)

Recurrent Glioblastoma: Where we stand
por: Roy, Sanjoy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ikv78876m25l8c73kj8ldh6opk